Vitamin D receptor ligands: the impact of crystal structures

Abstract

Introduction: In the past years, the biologically active form of vitamin D₃, 1α,25-dihydroxyvitamin D₃ (1α,25(OH)₂D₃), has received large appreciation due to the broad physiological impact of the hormone and its nuclear receptor, the transcription factor vitamin D receptor (VDR). Recently, the understanding of VDR actions has progressed greatly, due to VDR crystal structures with various ligands.

Areas covered: This review will present and discuss new synthetic agonistic and antagonistic 1α,25(OH)₂D₃ analogs in the context of the recent insights provided by VDR crystal structures.

Expert opinion: During the last 5 years, a large number of new 1α,25(OH)₂D₃ analogs, many of which have an interesting functional profile, have been patented. Moreover, for a surprisingly high number of 1α,25(OH)₂D₃ analogs, the crystal structure data of their complex with the VDR is available. This structural information provides important insight into the functional potential of the VDR ligands and explains their agonistic and antagonistic action. However, so far, only for a few VDR ligands, a rational design, based on crystal structure information, has been applied. The design of future analogs may also take the specificity of co-factor interaction into account, in order to create selective VDR modulators.

Keywords::

• agonists
• antagonists
• crystal structure
• nuclear receptor
• vitamin D
• vitamin D analogs
• vitamin D receptor

Notes

This box summarizes key points contained in the article.